These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22099686)

  • 1. Metabolic syndrome in obese adolescents is associated with risk for nephrolithiasis.
    Tiwari R; Campfield T; Wittcopp C; Braden G; Visintainer P; Reiter EO; Allen HF
    J Pediatr; 2012 Apr; 160(4):615-620.e2. PubMed ID: 22099686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis.
    Eisner BH; Eisenberg ML; Stoller ML
    Urology; 2010 Jun; 75(6):1289-93. PubMed ID: 20018350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristic clinical and biochemical profile of recurrent calcium-oxalate nephrolithiasis in patients with metabolic syndrome.
    Rendina D; De Filippo G; Zampa G; Muscariello R; Mossetti G; Strazzullo P
    Nephrol Dial Transplant; 2011 Jul; 26(7):2256-63. PubMed ID: 21051502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beware the low urine pH--the major cause of the increased prevalence of nephrolithiasis in the patient with type 2 diabetes.
    Bell DS
    Diabetes Obes Metab; 2012 Apr; 14(4):299-303. PubMed ID: 21992452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low urine pH: a novel feature of the metabolic syndrome.
    Maalouf NM; Cameron MA; Moe OW; Adams-Huet B; Sakhaee K
    Clin J Am Soc Nephrol; 2007 Sep; 2(5):883-8. PubMed ID: 17702734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome and uric acid nephrolithiasis.
    Sakhaee K; Maalouf NM
    Semin Nephrol; 2008 Mar; 28(2):174-80. PubMed ID: 18359398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome in obese Thai children and adolescents.
    Iamopas O; Chongviriyaphan N; Suthutvoravut U
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S126-32. PubMed ID: 22043765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
    Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
    J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance.
    Abate N; Chandalia M; Cabo-Chan AV; Moe OW; Sakhaee K
    Kidney Int; 2004 Feb; 65(2):386-92. PubMed ID: 14717908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of urine sodium on urine risk factors for calcium oxalate nephrolithiasis.
    Eisner BH; Eisenberg ML; Stoller ML
    J Urol; 2009 Nov; 182(5):2330-3. PubMed ID: 19758639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipidemia and kidney stone risk.
    Torricelli FC; De SK; Gebreselassie S; Li I; Sarkissian C; Monga M
    J Urol; 2014 Mar; 191(3):667-72. PubMed ID: 24055417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor analysis of metabolic syndrome components in obese women.
    Lafortuna CL; Adorni F; Agosti F; Sartorio A
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):233-41. PubMed ID: 17600693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females.
    Abdullah AR; Hasan HA; Raigangar VL
    Metab Syndr Relat Disord; 2009 Feb; 7(1):17-22. PubMed ID: 19025443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of BMI in nephrolithiasis in an Appalachian pediatric population: A single-center experience.
    Murphy MO; Erpelding SG; Chishti AS; Dugan A; Ziada A; Kiessling SG
    J Pediatr Urol; 2018 Aug; 14(4):330.e1-330.e8. PubMed ID: 29887297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic syndrome and nephrolithiasis].
    Kohjimoto Y; Iba A; Sasaki Y; Hara I
    Hinyokika Kiyo; 2011 Jan; 57(1):43-7. PubMed ID: 21304261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do the prevalence and components of metabolic syndrome differ among different ethnic groups? A cross-sectional study among obese Malaysian adolescents.
    Narayanan P; Meng OL; Mahanim O
    Metab Syndr Relat Disord; 2011 Oct; 9(5):389-95. PubMed ID: 21718129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome in obese children and adolescents: dichotomous or continuous?
    Thivel D; Malina RM; Isacco L; Aucouturier J; Meyer M; Duché P
    Metab Syndr Relat Disord; 2009 Dec; 7(6):549-55. PubMed ID: 19900159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stone forming risk factors in patients with type Ia glycogen storage disease.
    Scales CD; Chandrashekar AS; Robinson MR; Cantor DA; Sullivan J; Haleblian GE; Leitao VA; Sur RL; Borawski KM; Koeberl D; Kishnani PS; Preminger GM
    J Urol; 2010 Mar; 183(3):1022-5. PubMed ID: 20092831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.